載入...
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Schizophrenia affects approximately 1% of the population and continues to be associated with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications. An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clinical...
Na minha lista:
| 發表在: | Handb Exp Pharmacol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817347/ https://ncbi.nlm.nih.gov/pubmed/23027419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-642-25758-2_10 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|